Ear News and Research

RSS

Study uncovers genes that drive peanut allergy reactions

Mount Sinai researchers have identified six genes that activate hundreds of other genes in children experiencing severe allergic reactions to peanuts.

5 Dec 2017

Fish oil component provides long-term preconditioning protection for vision cells

A team of LSU Health New Orleans scientists discovered that a component of fish oil not only protects cells critical to vision from potentially lethal initial insults, but also from those that occur in the future.

1 Dec 2017

The ratcheting cost of the pneumococcal vaccine: What gives?

Every November, like clockwork, she gets the same letter, said Dr. Lindsay Irvin, a pediatrician in San Antonio.

29 Nov 2017

Study shows potential of neurofeedback in tinnitus treatment

A study presented today at the annual meeting of the Radiological Society of North America (RSNA) suggests that neurofeedback training has the potential to lessen the severity of tinnitus or even eliminate it.

27 Nov 2017

FDA approves first medical device system that can make adjustments to implanted lens after cataract surgery

The U.S. Food and Drug Administration today approved the RxSight Inc. Light Adjustable Lens and Light Delivery Device, the first medical device system that can make small adjustments to the artificial lens' power after cataract surgery so that the patient will have better vision when not using glasses.

22 Nov 2017

Genetic, ethnic background may be underlying factors for acquired laryngotracheal stenosis

Endotracheal intubation, in which a tube is inserted through the voice box (larynx) into the windpipe, and tracheotomy, in which surgery is undertaken to create a hole through the neck and into the windpipe (trachea) to facilitate breathing, are widely used in the hospital setting for elective surgery and in cases of serious illness or critical injury.

22 Nov 2017

Trial shows apple allergen as effective treatment option for birch pollen-related apple allergy

The food allergy, which is related to birch pollen, is a very common attendant phenomenon associated with birch pollen allergy - indeed around 70% of those with a birch pollen allergy are also allergic to apples. That amounts to around 280,000 people in Austria.

20 Nov 2017

FDA approves remote programming feature for Nucleus Cochlear Implant System via telemedicine

The U.S. Food and Drug Administration today approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform.

20 Nov 2017

Mount Sinai researchers identify new therapeutic target for ER+ breast cancer

Researchers at the Icahn School of Medicine at Mount Sinai have identified a protein that can be targeted to suppress growth of a common type of breast cancer known as "estrogen receptor positive" (ER+), including ER+ cancers that are resistant to standard treatments.

17 Nov 2017

NYU Langone launches new, comprehensive center for facial paralysis

Thousands of New Yorkers every year will suffer some form of facial paralysis, a diagnosis with many causes which can greatly affect a person's appearance and day-to-day functioning.

16 Nov 2017

FDA permits marketing of first electric stimulation device to reduce opioid withdrawal symptoms

Today, the U.S. Food and Drug Administration granted a new indication to an electric stimulation device for use in helping to reduce the symptoms of opioid withdrawal.

16 Nov 2017

New eyedropper delivers medication more precisely with less waste and reduced side effects

A new kind of eyedropper can deliver tiny droplets of medication, treating the eye more precisely than traditional eyedroppers, while reducing waste and avoiding dangerous side effects.

14 Nov 2017

Malaria parasites’ decision making influenced by fatty molecule in human blood

Depletion of a fatty molecule in human blood propels malaria parasites to stop replicating and causing illness in people and instead to jump ship to mosquitoes to continue the transmission cycle, according to a new study by an international research team.

9 Nov 2017

Novel mathematical model can predict how cancer patient will benefit from immunotherapies

Researchers at the Icahn School of Medicine at Mount Sinai have created the first mathematical model that can predict how a cancer patient will benefit from certain immunotherapies, according to a study published in Nature.

9 Nov 2017

Study shows promise and potential risk in reversing hearing loss using inner ear stem cells

Want to restore hearing by injecting stem cells into the inner ear? Well, that can be a double-edged sword.

7 Nov 2017

UMD study provides important insights into early sensory development

Some expectant parents play classical music for their unborn babies, hoping to boost their children's cognitive capacity later in life.

7 Nov 2017

Diabetes awareness month: Mount Sinai experts share tips for disease prevention

Diabetes is the seventh leading cause of death in the United States. Today, 29.1 million people in the United States have been diagnosed with diabetes, according to the U.S. Centers for Disease Control and Prevention.

3 Nov 2017

Study solves critical piece of deafness puzzle by identifying long non-coding RNAs

A new Tel Aviv University study solves a critical piece of the puzzle of human deafness by identifying the first group of long non-coding RNAs (lncRNAs) in the auditory system.

2 Nov 2017

Report reveals high risk of back, shoulder and other injuries for competitive divers

Competitive divers face a high risk of injuring their shoulders, back, elbows, wrists and other body parts, according to a report by a Loyola Medicine sports medicine physician.

30 Oct 2017

New gene drive approach helps pinpoint combination therapies against fungal pathogens

Candida albicans is a notorious human fungal pathogen that causes thrush and serious systemic infections. Opportunistic C. albicans fungi, which often live inconspicuously in the normal flora of human skin and gut, can switch from their harmless stealth mode to become aggressive pathogens, especially in people whose immune systems are already compromised by pre-existing diseases or harsh drug therapies.